Serum HSP70 level in patients with endometrial cancer with and without diabetes

References

• Klil-Drori AJ, Azoulay L, Pollak MN. Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol. 2016;14:85–99.
   PubMed Web of Science ®Google Scholar
• Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
   PubMed Web of Science ®Google Scholar
• Lukanova A, Lundin E, Micheli A, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer. 2004;108:425–432.
   PubMed Web of Science ®Google Scholar
• Lindemann K, Cvancarova M, Eskild A. Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-Survey. Gynecol Oncol. 2015;139:476–480.
   PubMed Web of Science ®Google Scholar
• Liao C, Zhang D, Mungo C, et al. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol. 2014;135:163–171.
   PubMed Web of Science ®Google Scholar
• Radons J. The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones. 2016;21:379–404.
   PubMed Web of Science ®Google Scholar
• Nakhjavani M, Morteza A, Khajeali L, et al. Increased serum HSP70 levels are associated with the duration of diabetes. Cell stress Chaperones. 2010;15:959–964.
   PubMed Web of Science ®Google Scholar
• Sherman MY, Gabai VL. Hsp70 in cancer: back to the future. Oncogene. 2015;34:4153–4161.
   PubMed Web of Science ®Google Scholar
• Thomas X, Campos L, Mounier C, et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res. 2005;29:1049–1058.
   PubMed Web of Science ®Google Scholar
• Sun XF, Zhang H, Carstensen J, et al. Heat shock protein 72/73 in relation to cytoplasmic p53 expression and prognosis in colorectal adenocarcinomas. Int J Cancer. 1997;74:600–604.
   PubMed Web of Science ®Google Scholar
• Chuma M, Sakamoto M, Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003;37:198–207.
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Clark GM, Tandon AK, et al. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst. 1993;85:570–574.
   PubMed Web of Science ®Google Scholar
• Ramp U, Mahotka C, Heikaus S, et al. Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosis. Histol Histopathol. 2007;22:1099–1108.
   PubMed Web of Science ®Google Scholar
• Nakajima M, Kuwano H, Miyazaki T, et al. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett. 2002;178:99–106.
   PubMed Web of Science ®Google Scholar
• Nanbu K, Konishi I, Komatsu T, et al. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Cancer. 1996;77:330–338.
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10:86–103.
   PubMed Web of Science ®Google Scholar
• Carcangiu ML, Chambers JT, Voynick IM, et al. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol. 1990;94:247–254.
   PubMed Web of Science ®Google Scholar
• Deligdisch L, Holinka CF. Progesterone receptors in two groups of endometrial carcinoma. Cancer. 1986;57:1385–1388.
   PubMed Web of Science ®Google Scholar
• Ciocca DR, Luque EH. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Tr. 1991;20:33–42.
   PubMed Web of Science ®Google Scholar
• Koshiyama M, Konishi I, Nanbu K, et al. Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: correlation with sex steroid receptors and Ki-67 antigen expression. J Clin Endocrinol Metab. 1995;80:1106–1112.
   PubMed Web of Science ®Google Scholar
• Edwards DP, Estes PA, Fadok VA, et al. Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo. Biochemistry. 1992;31:2482–2491.
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Gong J. Heat shock proteins promote cancer: it’s a protection racket. Trends Biochem Sci. 2016;41:311–323.
   PubMed Web of Science ®Google Scholar
• Qu B, Jia Y, Liu Y, et al. The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review. Cell Stress Chaperones. 2015;20:885–892.
   PubMed Web of Science ®Google Scholar
• Dempsey NC, Leoni F, Ireland HE, et al. Differential heat shock protein localization in chronic lymphocytic leukemia. J Leukoc Biol. 2010;87:467–476.
   PubMed Web of Science ®Google Scholar
• Friberg E, Orsini N, Mantzoros C, et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Berlin, Germany: Springer; 2007.
   Google Scholar
• Yeh CH, Tseng R, Hannah A, et al. Clinical correlation of circulating heat shock protein 70 in acute leukemia. Leuk Res. 2010;34:605–609.
   PubMed Web of Science ®Google Scholar
• Rozenberg P, Kocsis J, Saar M, et al. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer. Int J Cancer. 2013;133:514–518.
   PubMed Web of Science ®Google Scholar
• Gehrmann M, Specht HM, Bayer C, et al. Hsp70–a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol. 2014;9:131.
   PubMed Web of Science ®Google Scholar
• De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. Cell Stress and Chaperones. 2011;16:235–249.
   PubMed Web of Science ®Google Scholar
• Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci. 2005;62:670–684.
   PubMed Web of Science ®Google Scholar
• Dossus L, Becker S, Rinaldi S, et al. Tumor necrosis factor (TNF)-alpha, soluble TNF receptors and endometrial cancer risk: the EPIC study. Int J Cancer. 2011;129:2032–2037.
   PubMed Web of Science ®Google Scholar
• Wang T, Rohan TE, Gunter MJ, et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers. Cancer Epidemiol Biomarkers Prev. 2011;20:971–977.
   PubMed Web of Science ®Google Scholar
• Shiozawa T, Konishi I. Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment. Int J Clin Oncol. 2006;11:13–21.
   PubMedGoogle Scholar